We are live on ! Find out more
AMED

Amedisys

Delisted

AMED was delisted on the 14th of August, 2025.

168 hedge funds and large institutions have $1.57B invested in Amedisys in 2016 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 59 increasing their positions, 67 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

52% more call options, than puts

Call options by funds: $3.14M | Put options by funds: $2.07M

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

7% more capital invested

Capital invested by funds: $1.46B → $1.57B (+$108M)

0% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 21

1% less funds holding

Funds holding: 169168 (-1)

12% less repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 67

Holders
168
Holders Change
-1
Holders Change %
-0.59%
% of All Funds
4.48%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.08%
New
21
Increased
59
Reduced
67
Closed
21
Calls
$3.14M
Puts
$2.07M
Net Calls
+$1.07M
Net Calls Change
+$3.32M
Name Holding Trade Value Shares
Change
Change in
Stake
KKRC
1
Kohlberg Kravis Roberts & Co
New York
$244M
Fidelity Investments
2
Fidelity Investments
Massachusetts
$161M -$121K -2,400 -0.1%
Vanguard Group
3
Vanguard Group
Pennsylvania
$157M +$1.71M +33,785 +1%
BFA
4
BlackRock Fund Advisors
California
$96.6M +$1.2M +23,831 +1%
Wells Fargo
5
Wells Fargo
California
$84.7M +$79.1M +1,567,227 +1,424%
Dimensional Fund Advisors
6
Dimensional Fund Advisors
Texas
$78M -$371K -7,350 -0.5%
BA
7
BlackRock Advisors
Delaware
$50.3M -$476K -9,434 -0.9%
RIM
8
RS Investment Management
California
$40.5M -$26.2K -519 -0.1%
Northern Trust
9
Northern Trust
Illinois
$38.2M +$107K +2,113 +0.3%
William Blair Investment Management
10
William Blair Investment Management
Illinois
$37.2M -$3.88M -76,908 -9%
State Street
11
State Street
Massachusetts
$36.3M +$1.6M +31,770 +5%
BIT
12
BlackRock Institutional Trust
California
$35.1M -$551K -10,911 -2%
Acadian Asset Management
13
Acadian Asset Management
Massachusetts
$32.2M -$338K -6,702 -1%
Renaissance Technologies
14
Renaissance Technologies
New York
$32M +$106K +2,100 +0.3%
BG
15
BlackRock Group
United Kingdom
$26.8M -$1.08M -21,382 -4%
Norges Bank
16
Norges Bank
Norway
$17.9M +$531K +10,515 +3%
RCAMU
17
Rothschild & Co Asset Management US
Connecticut
$17.7M +$1.59M +31,434 +10%
Bank of New York Mellon
18
Bank of New York Mellon
New York
$16.8M -$5.99M -118,722 -26%
CAM
19
Cortina Asset Management
Wisconsin
$14.8M -$265K -5,260 -2%
D.E. Shaw & Co
20
D.E. Shaw & Co
New York
$14.7M -$2.88M -57,080 -16%
SFM
21
Systematic Financial Management
New Jersey
$12.1M -$3.84M -76,120 -24%
Marshall Wace
22
Marshall Wace
United Kingdom
$11.4M +$6.26M +123,938 +122%
EA
23
Emerald Acquisition
Washington
$10.9M +$10.9M +215,701 New
Geode Capital Management
24
Geode Capital Management
Massachusetts
$10.5M +$89.5K +1,774 +0.9%
Principal Financial Group
25
Principal Financial Group
Iowa
$10.3M +$127K +2,519 +1%

AMED Hedge Fund Activity: Q2 2016 in Review

168 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q2 2016, worth a combined $1.57B — up 7.4% from $1.46B a quarter earlier.

Fund positioning in AMED was balanced in Q2 2016: 21 funds opened new positions, 21 closed out, 59 added to existing stakes and 67 trimmed.

The largest buyer was Wells Fargo, adding an estimated $79.1M. The largest seller was North Tide Capital, exiting entirely with an estimated $24.2M sold.

  • 168 institutional investors held Amedisys (AMED) as of Q2 2016, down from 169 in Q1 2016.
  • Funds reported $1.57B of Amedisys stock for Q2 2016, up 7.4% quarter-over-quarter.
  • 21 funds opened new Amedisys positions in Q2 2016 and 21 closed out, a net change of 0 holders.
  • The largest Amedisys buyer in Q2 2016 was Wells Fargo, an estimated $79.1M added.
  • The largest Amedisys seller in Q2 2016 was North Tide Capital, an estimated $24.2M sold.

Based on aggregated 13F filings for Q2 2016.